Swiss National Bank Cuts Stock Position in Option Care Health, Inc. (NASDAQ:OPCH)

Swiss National Bank trimmed its holdings in Option Care Health, Inc. (NASDAQ:OPCH - Free Report) by 10.3% in the 4th quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 354,500 shares of the company's stock after selling 40,700 shares during the quarter. Swiss National Bank owned approximately 0.20% of Option Care Health worth $11,943,000 as of its most recent SEC filing.

A number of other institutional investors have also added to or reduced their stakes in the stock. First Horizon Advisors Inc. bought a new position in Option Care Health during the third quarter valued at approximately $37,000. Headlands Technologies LLC grew its holdings in shares of Option Care Health by 5,796.7% in the third quarter. Headlands Technologies LLC now owns 1,769 shares of the company's stock valued at $57,000 after purchasing an additional 1,739 shares in the last quarter. Fifth Third Bancorp increased its position in Option Care Health by 219.6% in the third quarter. Fifth Third Bancorp now owns 2,723 shares of the company's stock worth $88,000 after purchasing an additional 1,871 shares during the last quarter. Parkside Financial Bank & Trust raised its stake in Option Care Health by 24,250.0% during the fourth quarter. Parkside Financial Bank & Trust now owns 2,922 shares of the company's stock valued at $98,000 after purchasing an additional 2,910 shares in the last quarter. Finally, International Assets Investment Management LLC lifted its position in Option Care Health by 1,513.7% during the fourth quarter. International Assets Investment Management LLC now owns 3,066 shares of the company's stock valued at $103,000 after purchasing an additional 2,876 shares during the last quarter. 98.05% of the stock is owned by hedge funds and other institutional investors.

Wall Street Analyst Weigh In

Several brokerages have recently issued reports on OPCH. Jefferies Financial Group upped their target price on shares of Option Care Health from $36.00 to $38.00 and gave the company a "buy" rating in a research report on Monday, March 4th. Barrington Research reaffirmed an "outperform" rating and issued a $38.00 price objective on shares of Option Care Health in a research note on Wednesday, April 24th.

Option Care Health Trading Down 0.5 %

NASDAQ:OPCH traded down $0.16 during mid-day trading on Friday, hitting $30.12. 1,021,221 shares of the stock traded hands, compared to its average volume of 1,761,457. The company has a quick ratio of 1.39, a current ratio of 1.77 and a debt-to-equity ratio of 0.74. The firm's 50 day moving average is $31.46 and its two-hundred day moving average is $31.32. Option Care Health, Inc. has a 52 week low of $26.17 and a 52 week high of $35.74. The stock has a market capitalization of $5.24 billion, a price-to-earnings ratio of 19.82, a PEG ratio of 1.46 and a beta of 1.26.

Option Care Health (NASDAQ:OPCH - Get Free Report) last released its earnings results on Tuesday, April 23rd. The company reported $0.26 earnings per share for the quarter, topping analysts' consensus estimates of $0.22 by $0.04. The business had revenue of $1.15 billion for the quarter, compared to analyst estimates of $1.10 billion. Option Care Health had a return on equity of 18.92% and a net margin of 6.15%. The business's revenue was up 12.8% compared to the same quarter last year. During the same quarter last year, the firm posted $0.21 earnings per share. On average, equities research analysts predict that Option Care Health, Inc. will post 1.19 earnings per share for the current year.

Insider Activity at Option Care Health

In related news, Director Harry M. Jansen Kraemer, Jr. bought 35,000 shares of Option Care Health stock in a transaction dated Monday, February 26th. The shares were acquired at an average cost of $31.55 per share, with a total value of $1,104,250.00. Following the completion of the transaction, the director now owns 269,528 shares in the company, valued at approximately $8,503,608.40. The purchase was disclosed in a filing with the SEC, which can be accessed through this link. 0.64% of the stock is currently owned by company insiders.

Option Care Health Company Profile

Option Care Health, Inc offers home and alternate site infusion services in the United States. The company provides anti-infective therapies; home infusion services to treat heart failures; home parenteral nutrition and enteral nutrition support services for numerous acute and chronic conditions, such as stroke, cancer, and gastrointestinal diseases; immunoglobulin infusion therapies for the treatment of immune deficiencies; and treatments for chronic inflammatory disorders, including crohn's disease, plaque psoriasis, psoriatic arthritis, rheumatoid arthritis, ulcerative colitis, and other chronic inflammatory disorders.